Andrew Hirsch C4 Therapeutics, Inc. (CCCC) insider trading activity

CCCC Quotes by TradingView

Andrew Hirsch is President & CEO of C4 Therapeutics, Inc.. Currently has a direct ownership of 210,741 shares of CCCC, which is worth approximately $1.23 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 6,560 shares (Common Stock) at a price of $7.9 per share, resulting in proceeds of $51,824. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K
0% 3M change
85.02% 12M change
Total Value Held $1.23 Million

Andrew Hirsch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
SELL
Payment of exercise price or tax liability
$51,824 $7.9 p/Share
6,560 Reduced 3.02%
210,741 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
103,400 Added 32.24%
217,301 Common Stock
Aug 30 2023
SELL
Payment of exercise price or tax liability
$6,460 $2.93 p/Share
2,205 Reduced 1.9%
113,901 Common Stock
Aug 30 2023
BUY
Exercise of conversion of derivative security
-
7,500 Added 6.07%
116,106 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
81,600 Added 42.9%
108,606 Common Stock
Jan 30 2023
SELL
Payment of exercise price or tax liability
$33,601 $7.78 p/Share
4,319 Reduced 13.79%
27,006 Common Stock
Jan 30 2023
BUY
Exercise of conversion of derivative security
-
12,500 Added 28.52%
31,325 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
-
12,500 Added 35.71%
22,500 Common Stock
Apr 12 2022
BUY
Open market or private purchase
$84,000 $8.4 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

EDIT
Editas Medicine, Inc. Healthcare
Director
AH

Andrew Hirsch

President & CEO
Cambridge, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCCC